ArticleFrontiers in oncology2020

Case Report: Herceptin as a Potentially Valuable Adjuvant Therapy for a Patient With Human Epidermal Growth Factor Receptor 2-Positive Advanced Esophageal Squamous Cell Carcinoma.

Li Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.